Does ASUNAPREVIR Cause Hepatocellular carcinoma? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Hepatocellular carcinoma have been filed in association with ASUNAPREVIR. This represents 4.1% of all adverse event reports for ASUNAPREVIR.
42
Reports of Hepatocellular carcinoma with ASUNAPREVIR
4.1%
of all ASUNAPREVIR reports
2
Deaths
23
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From ASUNAPREVIR?
Of the 42 reports, 2 (4.8%) resulted in death, 23 (54.8%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ASUNAPREVIR. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does ASUNAPREVIR Cause?
Pyrexia (72)
Off label use (67)
Alanine aminotransferase increased (65)
Virologic failure (61)
Viral mutation identified (53)
Hepatic function abnormal (44)
Liver injury (41)
Liver disorder (37)
Ascites (34)
Renal impairment (34)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which ASUNAPREVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
ASUNAPREVIR vs ATACAND
ASUNAPREVIR vs ATAZANAVIR
ASUNAPREVIR vs ATAZANAVIR\COBICISTAT
ASUNAPREVIR vs ATAZANAVIR\RITONAVIR
ASUNAPREVIR vs ATENOLOL